Kolexia
Dreno Brigitte Dermatologie
Dreno Brigitte
Dermatologie
Hôpital Hôtel-Dieu Nantes
Nantes, France
929 Activités
9 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Acné juvénile Tumeurs cutanées Carcinomes Cicatrice Métastase tumorale Carcinome basocellulaire Lymphomes Carcinome épidermoïde

Collaborateurs

Voir plus
Quereux Gaelle
Quereux Gaelle
Hôpital Hôtel-Dieu Nantes, Nantes, France
Saint-Jean Melanie
Saint-Jean Melanie
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Peuvrel Lucie
Peuvrel Lucie
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Lebbe Celeste
Lebbe Celeste
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
BMS
47 collaboration(s)
Dernière en 2023
Galderma
46 collaboration(s)
Dernière en 2023
COSMETIQUE ACTIVE INTERNATIONAL
28 collaboration(s)
Dernière en 2023
Pierre Fabre
20 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
RIC-Mel: French National Cohort of Patients With Melanoma (Any Stage). Network for Research and Clinical Investigation, the RIC-Mel Network.
Essai Clinique (BMS)   18 mars 2024
European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
Journal of the European Academy of Dermatology and Venereology : JEADV   07 mars 2024
Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study.
Acta dermato-venereologica   21 février 2024
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors: A Phase I/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination With Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced Solid Tumors
Essai Clinique (BMS)   06 février 2024
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Dermatology and therapy   12 janvier 2024
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067): A Phase 3, Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab Versus Ipilimumab Monotherapy in Subjects With Previously Untreated Unresectable or Metastatic Melanoma
Essai Clinique (BMS)   05 janvier 2024
A dermocosmetic regimen is able to mitigate skin sensitivity induced by a retinoid-based fixed combination treatment for acne: Results of a randomized clinical trial.
Journal of cosmetic dermatology   15 décembre 2023
A Salicylic Acid-Based Dermocosmetic is Effective as an Adjunct to Benzoyl Peroxide for Mild to Moderate Acne and as Monotherapy in Maintenance Post Benzoyl Peroxide.
Journal of drugs in dermatology : JDD   07 décembre 2023
Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).
Journal of neurology   06 décembre 2023
Exposition solaire : connaissances et comportements des patients ayant été traités pour un cancer cutané
Journées dermatologiques de Paris 2023   01 décembre 2023